首页 > 最新文献

Journal of Korean Neurosurgical Society最新文献

英文 中文
Surgical Thrombectomy for Extensive Cerebral Venous Sinus Thrombosis after COVID-19 Vaccination : A Novel Surgical Technique and Literature Review. COVID-19疫苗接种后广泛脑静脉窦血栓形成的外科血栓切除术:一种新的外科技术和文献综述。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-03-02 DOI: 10.3340/jkns.2023.0026
Yuwhan Chung, Jiwook Ryu, Seok Keun Choi

Surgical treatment of refractory and extensive cerebral venous sinus thrombosis (CVST) has limited applications. Here, we describe an open, direct sinus thrombectomy in the early phase of extensive CVST. A 49-year-old man with extensive CVST that occurred after the coronavirus disease 2019 (COVID-19) vaccination and affected the drainage of the Labbé vein presented with clinical deterioration and left temporal hemorrhagic infarction. Since the patient had extensive CVST, we determined that systemic anticoagulation and endovascular treatment were not suitable treatment options. Therefore, we decided on an emergency surgical treatment and performed direct surgical thrombectomy. We followed extended suboccipital approach and made multiple incisions on the sinuses, exposing the posterior superior sagittal sinus to the transverse sigmoid junction. Consequently, the clinical condition of the patient dramatically improved, resulting in a favorable outcome with a modified Rankin scale score of 0. Performing emergency open surgical thrombectomy was a technically feasible treatment option that recanalize obstructed sinuses. Importantly, the patient recovered with a good clinical outcome. Early maximal surgical thrombectomy can be an effective and lifesaving method to treat extensive CVST with hemorrhagic infarction.

手术治疗难治性和广泛性脑静脉窦血栓形成(CVST)的应用非常有限。在此,我们描述了在广泛 CVST 早期阶段的开放式直接窦血栓切除术。一名 49 岁的男性患者在接种冠状病毒病 2019(COVID-19)疫苗后发生了广泛的 CVST,并影响了拉贝静脉的引流,出现了临床恶化和左颞部出血性梗死。由于患者患有广泛的 CVST,我们认为全身抗凝和血管内治疗并不是合适的治疗方案。因此,我们决定采取紧急手术治疗,并直接进行了手术血栓切除术。我们采用枕下延伸入路,在鼻窦上做了多个切口,暴露了后上矢状窦到乙状结肠横交界处。急诊开放手术血栓切除术是一种技术上可行的治疗方案,可以重新疏通阻塞的静脉窦。重要的是,患者康复后临床疗效良好。早期最大限度的外科血栓切除术是治疗大面积 CVST 出血性梗死的有效救命方法。
{"title":"Surgical Thrombectomy for Extensive Cerebral Venous Sinus Thrombosis after COVID-19 Vaccination : A Novel Surgical Technique and Literature Review.","authors":"Yuwhan Chung, Jiwook Ryu, Seok Keun Choi","doi":"10.3340/jkns.2023.0026","DOIUrl":"10.3340/jkns.2023.0026","url":null,"abstract":"<p><p>Surgical treatment of refractory and extensive cerebral venous sinus thrombosis (CVST) has limited applications. Here, we describe an open, direct sinus thrombectomy in the early phase of extensive CVST. A 49-year-old man with extensive CVST that occurred after the coronavirus disease 2019 (COVID-19) vaccination and affected the drainage of the Labbé vein presented with clinical deterioration and left temporal hemorrhagic infarction. Since the patient had extensive CVST, we determined that systemic anticoagulation and endovascular treatment were not suitable treatment options. Therefore, we decided on an emergency surgical treatment and performed direct surgical thrombectomy. We followed extended suboccipital approach and made multiple incisions on the sinuses, exposing the posterior superior sagittal sinus to the transverse sigmoid junction. Consequently, the clinical condition of the patient dramatically improved, resulting in a favorable outcome with a modified Rankin scale score of 0. Performing emergency open surgical thrombectomy was a technically feasible treatment option that recanalize obstructed sinuses. Importantly, the patient recovered with a good clinical outcome. Early maximal surgical thrombectomy can be an effective and lifesaving method to treat extensive CVST with hemorrhagic infarction.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"578-585"},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9363106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spinal Cord Malakoplakia Mimicking a Spinal Cord Tumor : The First Case Report. 模仿脊髓肿瘤的脊髓恶性肿瘤:首例病例报告
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-28 DOI: 10.3340/jkns.2024.0077
JongGyu Lee, Jong Un Lee, Kwang-Ryeol Kim, Dae-Hyun Kim

Malakoplakia is a rare chronic inflammatory disease that has been rarely reported in the genitourinary tract, gastrointestinal tract, adrenal glands, skin, lungs, bone, and endometrium. Central nervous system malakoplakia is extremely rare, and even then, it has only been reported in the cerebrum and cerebellum. A definite diagnosis of malakoplakia depends on microscopic detection of Michaelis-Gutmann bodies. We would like to present the case of a 61-year-old male who, after undergoing a liver transplant and receiving prolonged antibiotic treatment for Escherichia coli bacteremia, presented with quadriparesis and gait disturbance. The clinical and radiologic appearance of malakoplakia mimics that of malignant tumor. This is a condition with no established appropriate treatment and presents challenges due to its spinal cord location. However, this case presents a case of spinal cord malakoplakia and may provide newly differential diagnosis of an intramedullary mass in the spinal cord.

恶性角化病是一种罕见的慢性炎症性疾病,在泌尿生殖道、胃肠道、肾上腺、皮肤、肺、骨和子宫内膜中很少见报道。中枢神经系统恶性肿瘤极为罕见,即便如此,也仅在大脑和小脑中有报道。恶性角化病的明确诊断取决于显微镜下 Michaelis-Gutmann 体的检测。我们要介绍的病例是一名 61 岁的男性,在接受肝移植手术并因大肠埃希菌菌血症接受长期抗生素治疗后,出现四肢瘫痪和步态障碍。恶性肿瘤的临床和放射学表现与恶性肿瘤相似。这种病症目前还没有确定合适的治疗方法,而且由于其位于脊髓部位,因此治疗难度很大。不过,本病例是一例脊髓恶性肿瘤病例,可提供脊髓髓内肿块的新鉴别诊断。
{"title":"Spinal Cord Malakoplakia Mimicking a Spinal Cord Tumor : The First Case Report.","authors":"JongGyu Lee, Jong Un Lee, Kwang-Ryeol Kim, Dae-Hyun Kim","doi":"10.3340/jkns.2024.0077","DOIUrl":"https://doi.org/10.3340/jkns.2024.0077","url":null,"abstract":"<p><p>Malakoplakia is a rare chronic inflammatory disease that has been rarely reported in the genitourinary tract, gastrointestinal tract, adrenal glands, skin, lungs, bone, and endometrium. Central nervous system malakoplakia is extremely rare, and even then, it has only been reported in the cerebrum and cerebellum. A definite diagnosis of malakoplakia depends on microscopic detection of Michaelis-Gutmann bodies. We would like to present the case of a 61-year-old male who, after undergoing a liver transplant and receiving prolonged antibiotic treatment for Escherichia coli bacteremia, presented with quadriparesis and gait disturbance. The clinical and radiologic appearance of malakoplakia mimics that of malignant tumor. This is a condition with no established appropriate treatment and presents challenges due to its spinal cord location. However, this case presents a case of spinal cord malakoplakia and may provide newly differential diagnosis of an intramedullary mass in the spinal cord.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical Thrombectomy for Hyperacute Vertebrobasilar Ischemic Stroke via Nondominant Vertebral Artery : Clinical Experience and Considerations. 通过非支配椎动脉治疗超急性椎基底动脉缺血性中风的机械取栓术:临床经验和注意事项。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-28 DOI: 10.3340/jkns.2024.0104
Gi Yun Lee, ChanHyang Yang, Chul-Hoo Kang, Joong Goo Kim, Jin-Deok Joo, You Nam Chung, Ji Soon Huh, Jeong Jin Park, Jin Pyeong Jeon, Jong-Kook Rhim

Objective: The dominant vertebral artery (VA) approach is primarily considered in mechanical thrombectomy (MT) for acute occlusion of the vertebrobasilar (VB) artery. As accessing the dominant artery is sometimes difficult, we present our experience treating acute VB stroke via a nondominant VA approach through a comparison with the dominant VA approach.

Methods: Among 2,785 patients diagnosed with hyperacute ischemic stroke between January 2014 and December 2022, 50 patients with VB ischemic stroke underwent recanalization therapy through either dominant, nondominant, or bilateral VA approach. We evaluated patient characteristics and clinical course, highlighting the pros and cons of the access routes.

Results: The patients with hyperacute VB ischemic stroke were predominantly male (72%), with a mean age of 68.12 years and an initial National Institutes of Health Stroke Scale (NIHSS) score mean of 17.1. Large-artery atherosclerosis (LAA, 48%) and cardio-embolism (CE, 36%) were the main etiologic factors in the TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification. After thrombectomy, 45 (90%) cases had final modified thrombolysis in cerebral infarction (mTICI) score of 2b or higher. In summary, 41 patients were treated through the dominant VA, and 8 patients underwent the nondominant VA approach. However, there was no statistically significant difference in functional outcome or mortality between the two approaches.

Conclusion: In MT for VB occlusions, nondominant VA approach may be an option in situations when the vessel is accessible, stable, or less risky, as recanalization can be achieved without rescue balloon angioplasty and/or stenting.

目的:在治疗椎-基底动脉(VB)急性闭塞的机械取栓术(MT)中,主要考虑采用优势椎动脉(VA)入路。由于有时难以进入优势动脉,我们通过与优势椎动脉途径的比较,介绍了我们通过非优势椎动脉途径治疗急性椎基底动脉卒中的经验:在2014年1月至2022年12月期间确诊的2785名超急缺血性卒中患者中,50名VB缺血性卒中患者通过优势、非优势或双侧VA途径接受了再通治疗。我们评估了患者的特征和临床病程,强调了入路的利弊:超急性 VB 缺血性卒中患者主要为男性(72%),平均年龄为 68.12 岁,最初的美国国立卫生研究院卒中量表(NIHSS)平均评分为 17.1 分。大动脉粥样硬化(LAA,占 48%)和心肌栓塞(CE,占 36%)是 TOAST(急性中风治疗中的 Org 10172 试验)分类中的主要病因。血栓切除术后,45 例(90%)患者的脑梗塞改良溶栓术(mTICI)最终评分为 2b 或更高。总之,41 名患者通过优势 VA 方法进行了治疗,8 名患者通过非优势 VA 方法进行了治疗。然而,两种方法在功能预后或死亡率方面没有统计学意义上的显著差异:结论:在MT治疗VB闭塞时,如果血管通畅、稳定或风险较低,可以选择非显性VA入路,因为无需球囊血管成形术和/或支架植入术即可实现再通畅。
{"title":"Mechanical Thrombectomy for Hyperacute Vertebrobasilar Ischemic Stroke via Nondominant Vertebral Artery : Clinical Experience and Considerations.","authors":"Gi Yun Lee, ChanHyang Yang, Chul-Hoo Kang, Joong Goo Kim, Jin-Deok Joo, You Nam Chung, Ji Soon Huh, Jeong Jin Park, Jin Pyeong Jeon, Jong-Kook Rhim","doi":"10.3340/jkns.2024.0104","DOIUrl":"https://doi.org/10.3340/jkns.2024.0104","url":null,"abstract":"<p><strong>Objective: </strong>The dominant vertebral artery (VA) approach is primarily considered in mechanical thrombectomy (MT) for acute occlusion of the vertebrobasilar (VB) artery. As accessing the dominant artery is sometimes difficult, we present our experience treating acute VB stroke via a nondominant VA approach through a comparison with the dominant VA approach.</p><p><strong>Methods: </strong>Among 2,785 patients diagnosed with hyperacute ischemic stroke between January 2014 and December 2022, 50 patients with VB ischemic stroke underwent recanalization therapy through either dominant, nondominant, or bilateral VA approach. We evaluated patient characteristics and clinical course, highlighting the pros and cons of the access routes.</p><p><strong>Results: </strong>The patients with hyperacute VB ischemic stroke were predominantly male (72%), with a mean age of 68.12 years and an initial National Institutes of Health Stroke Scale (NIHSS) score mean of 17.1. Large-artery atherosclerosis (LAA, 48%) and cardio-embolism (CE, 36%) were the main etiologic factors in the TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification. After thrombectomy, 45 (90%) cases had final modified thrombolysis in cerebral infarction (mTICI) score of 2b or higher. In summary, 41 patients were treated through the dominant VA, and 8 patients underwent the nondominant VA approach. However, there was no statistically significant difference in functional outcome or mortality between the two approaches.</p><p><strong>Conclusion: </strong>In MT for VB occlusions, nondominant VA approach may be an option in situations when the vessel is accessible, stable, or less risky, as recanalization can be achieved without rescue balloon angioplasty and/or stenting.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neovascularization in Outer Membrane of Chronic Subdural Hematoma : A Rationale for Middle Meningeal Artery Embolization. 慢性硬膜下血肿外膜的新生血管:脑膜中动脉栓塞术的原理。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-26 DOI: 10.3340/jkns.2024.0101
Hadeel M Mansour, Bipin Chaurasia
{"title":"Neovascularization in Outer Membrane of Chronic Subdural Hematoma : A Rationale for Middle Meningeal Artery Embolization.","authors":"Hadeel M Mansour, Bipin Chaurasia","doi":"10.3340/jkns.2024.0101","DOIUrl":"https://doi.org/10.3340/jkns.2024.0101","url":null,"abstract":"","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Angiographic Outcomes of Endovascular Treatment for Acute Intracranial Vertebral Artery Dissecting Aneurysms Using Double-Overlapping Stents : Low-Profile Visualized Intraluminal Support within Enterprise Stents. 使用双重叠支架对急性颅内椎动脉夹层动脉瘤进行血管内治疗的临床和血管造影结果 :企业支架内的低调可视化腔内支撑。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-01 Epub Date: 2023-12-22 DOI: 10.3340/jkns.2023.0224
Ja Ho Koo, Eui Hyun Hwang, Ji Hye Song, Yong Cheol Lim

Objective: The use of reconstructive treatment with a double-overlapping stents has proven to be effective and safe in the current treatment of intracranial vertebral artery dissecting aneurysms (VADAs). We employed a combination of overlapping stents, using low-profile visualized intraluminal support (LVIS) within the Enterprise stent. This combination was chosen to minimize the outward bulging of the inner LVIS by overlapping it with the Enterprise stent while maintaining flow diversion and stability. This study aimed to evaluate the clinical and angiographic outcomes following the use of double-overlapping stents with LVIS within the Enterprise stent for the treatment of VADAs.

Methods: From March 2016 to January 2022, total 28 patients with unruptured VADAs were treated with the double-overlapping stent technique using LVIS within an Enterprise stent in our institute. The Enterprise stent was deployed first, followed by the LVIS stent. Patient clinical and angiographic characteristics, procedural complications, and follow-up outcomes were retrospectively reviewed.

Results: All 28 patients (18 males and 10 females) were successfully treated with double-overlapping stent deployment. There were no procedural complications or new neurological deficits in any patient. Of the 28 patients, four VADAs had posterior inferior cerebellar artery involvement. Procedure-related parent artery occlusion did not occur during the angiographic follow-up conducted 6 to 12 months after the procedure. Out of 28 patients, 24 showed complete healing, three had focal residual stenosis or dilatation with residual sac and only one had a residual dissecting flap with aneurysm. All patients, including the four patients, did not require any additional procedures. The postoperative modified Rankin scale scores were 0-1 for all patients.

Conclusion: A double-overlapping stent, with a flow-diversion effect, is a safe and effective treatment for patients with VADAs. In particular, when using the LVIS stent within an Enterprise stent, it minimizes the bulging of the inner LVIS stent while maintaining flow diversion and stability. Therefore, both can be effectively utilized as overlapping stents.

目的:在目前治疗颅内椎动脉夹层动脉瘤(VADA)的方法中,使用双重叠支架进行重建治疗已被证明是有效且安全的。我们采用了重叠支架组合,在 Enterprise 支架内使用低调的可视腔内支撑(LVIS)。选择这种组合是为了在保持血流分流和稳定性的同时,通过与 Enterprise 支架重叠,最大限度地减少 LVIS 内部的外凸。本研究旨在评估在Enterprise支架内使用带LVIS的双重叠支架治疗VADAs后的临床和血管造影结果:方法:2016年3月至2022年1月,我院共对28例未破裂的VADA患者进行了企业支架内LVIS双重叠支架技术治疗。首先部署Enterprise支架,然后部署LVIS支架。对患者的临床和血管造影特征、手术并发症和随访结果进行了回顾性分析:结果:所有28名患者(18男10女)均成功接受了双重叠支架置入术。所有患者均未出现手术并发症或新的神经功能缺损。在28名患者中,有4名患者的小脑后下动脉受累。在术后6至12个月的血管造影随访中,没有发生与手术相关的母动脉闭塞。在 28 名患者中,24 人完全愈合,3 人有局灶性残余狭窄或扩张并伴有残囊,只有 1 人有带动脉瘤的残余剥离瓣。包括这四名患者在内的所有患者都无需进行任何其他手术。所有患者的术后改良Rankin量表(mRS)评分均为0-1分:结论:具有血流分流作用的双层重叠支架是治疗 VADA 患者的一种安全有效的方法。尤其是在企业支架内使用 LVIS 支架时,可最大限度地减少 LVIS 内支架的隆起,同时保持血流分流和稳定性。因此,这两种支架可作为重叠支架有效使用。
{"title":"Clinical and Angiographic Outcomes of Endovascular Treatment for Acute Intracranial Vertebral Artery Dissecting Aneurysms Using Double-Overlapping Stents : Low-Profile Visualized Intraluminal Support within Enterprise Stents.","authors":"Ja Ho Koo, Eui Hyun Hwang, Ji Hye Song, Yong Cheol Lim","doi":"10.3340/jkns.2023.0224","DOIUrl":"10.3340/jkns.2023.0224","url":null,"abstract":"<p><strong>Objective: </strong>The use of reconstructive treatment with a double-overlapping stents has proven to be effective and safe in the current treatment of intracranial vertebral artery dissecting aneurysms (VADAs). We employed a combination of overlapping stents, using low-profile visualized intraluminal support (LVIS) within the Enterprise stent. This combination was chosen to minimize the outward bulging of the inner LVIS by overlapping it with the Enterprise stent while maintaining flow diversion and stability. This study aimed to evaluate the clinical and angiographic outcomes following the use of double-overlapping stents with LVIS within the Enterprise stent for the treatment of VADAs.</p><p><strong>Methods: </strong>From March 2016 to January 2022, total 28 patients with unruptured VADAs were treated with the double-overlapping stent technique using LVIS within an Enterprise stent in our institute. The Enterprise stent was deployed first, followed by the LVIS stent. Patient clinical and angiographic characteristics, procedural complications, and follow-up outcomes were retrospectively reviewed.</p><p><strong>Results: </strong>All 28 patients (18 males and 10 females) were successfully treated with double-overlapping stent deployment. There were no procedural complications or new neurological deficits in any patient. Of the 28 patients, four VADAs had posterior inferior cerebellar artery involvement. Procedure-related parent artery occlusion did not occur during the angiographic follow-up conducted 6 to 12 months after the procedure. Out of 28 patients, 24 showed complete healing, three had focal residual stenosis or dilatation with residual sac and only one had a residual dissecting flap with aneurysm. All patients, including the four patients, did not require any additional procedures. The postoperative modified Rankin scale scores were 0-1 for all patients.</p><p><strong>Conclusion: </strong>A double-overlapping stent, with a flow-diversion effect, is a safe and effective treatment for patients with VADAs. In particular, when using the LVIS stent within an Enterprise stent, it minimizes the bulging of the inner LVIS stent while maintaining flow diversion and stability. Therefore, both can be effectively utilized as overlapping stents.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"531-540"},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138830153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-Time Visualization of Thrombus during Suction Thrombectomy : Contrast-in-Stasis Technique. 抽吸血栓切除术中血栓的实时可视化:Stasis技术的对比。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-03 DOI: 10.3340/jkns.2023.0158
Yoon-Soo Lee

This report introduces a simple method to visualize the captured thrombus in real-time during suction thrombectomy using "contrast-in-stasis technique". It enables visualization of the thrombus captured by a suction catheter as it is being retrieved through the tortuous course of the carotid artery eventually into the guiding catheter. It also offers visual identification of important findings such as fragmentation of thrombus into pieces or loss of thrombus during retrieval, and, therefore, helps clinicians to make further critical decisions during the procedure.

本报告介绍了一种简单的方法,在抽吸血栓切除术中使用“淤滞对比技术”实时显示捕获的血栓。当血栓通过颈动脉的曲折过程最终进入引导导管时,它能够使抽吸导管捕获的血栓可视化。它还提供了重要发现的视觉识别,如血栓碎片化或取回过程中血栓丢失,因此,有助于临床医生在手术过程中做出进一步的关键决定。
{"title":"Real-Time Visualization of Thrombus during Suction Thrombectomy : Contrast-in-Stasis Technique.","authors":"Yoon-Soo Lee","doi":"10.3340/jkns.2023.0158","DOIUrl":"10.3340/jkns.2023.0158","url":null,"abstract":"<p><p>This report introduces a simple method to visualize the captured thrombus in real-time during suction thrombectomy using \"contrast-in-stasis technique\". It enables visualization of the thrombus captured by a suction catheter as it is being retrieved through the tortuous course of the carotid artery eventually into the guiding catheter. It also offers visual identification of important findings such as fragmentation of thrombus into pieces or loss of thrombus during retrieval, and, therefore, helps clinicians to make further critical decisions during the procedure.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"477-482"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11220417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71424195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Potential Risk of Radiation-Induced Cavernous Malformations Following Adjuvant Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy. 颞叶间叶癫痫伽玛刀辅助放射治疗后辐射诱发海绵状畸形的潜在风险。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-07 DOI: 10.3340/jkns.2023.0203
Junhyung Kim, Joonho Byun, Do Heui Lee, Seok Ho Hong

Objective: Several clinical studies have explored the feasibility and efficacy of radiosurgical treatment for mesial temporal lobe epilepsy, but the long-term safety of this treatment has not been fully characterized. This study aims to report and describe radiation-induced cavernous malformation as a delayed complication of radiosurgery in epilepsy patients.

Methods: The series includes 20 patients with mesial temporal lobe epilepsy who underwent Gamma Knife radiosurgery (GKRS). The majority received a prescribed isodose of 24 Gy as an adjuvant treatment after anterior temporal lobectomy.

Results: In this series, we identified radiation-induced cavernous malformation in three patients, resulting in a cumulative incidence of 18.4% (95% confidence interval, 6.3% to 47.0%) at an 8-year follow-up. These late sequelae of vascular malformation occurred between 6.9 and 7.6 years after GKRS, manifesting later than other delayed radiation-induced changes, such as radiation necrosis. Neurological symptoms attributed to intracranial hypertension were present in those three cases involving cavernous malformation. Of these, two cases, which initially exhibited an insufficient response to radiosurgery, ultimately demonstrated seizure remission following the successful microsurgical resection of the cavernous malformation.

Conclusion: All things considered, the development of radiation-induced cavernous malformation is not uncommon in this population and should be acknowledged as a potential long-term complication. Microsurgical resection of cavernous malformation can be preferentially considered in cases where the initial seizure outcome after GKRS is unsatisfactory.

目的:一些临床研究已经探讨了放射外科治疗内侧颞叶癫痫的可行性和疗效,但这种治疗的长期安全性尚未完全确定。本研究旨在报告和描述放射性海绵状畸形作为癫痫患者放射外科手术的延迟并发症。方法:该系列包括20例接受伽玛刀放射外科治疗的内侧颞叶癫痫患者。大多数患者在前颞叶切除术后接受了24Gy的处方等剂量辅助治疗。结果:在本系列中,我们在三名患者中发现了辐射诱导的海绵状畸形,在八年的随访中,累积发病率为18.4%(95%置信区间,6.3~47.0%)。这些血管畸形的晚期后遗症发生在GKRS后6.9至7.6年之间,比其他延迟的辐射诱导变化(如辐射坏死)表现得晚。这三例海绵状畸形患者均出现颅内高压引起的神经系统症状。其中,两例最初对放射外科治疗反应不足,但在成功显微外科切除海绵状畸形后,癫痫发作最终得到缓解。结论:综合考虑,放射性海绵状畸形的发展在这一人群中并不罕见,应该被认为是一种潜在的长期并发症。在GKRS后最初癫痫发作结果不令人满意的情况下,可以优先考虑海绵状畸形的显微手术切除。
{"title":"A Potential Risk of Radiation-Induced Cavernous Malformations Following Adjuvant Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy.","authors":"Junhyung Kim, Joonho Byun, Do Heui Lee, Seok Ho Hong","doi":"10.3340/jkns.2023.0203","DOIUrl":"10.3340/jkns.2023.0203","url":null,"abstract":"<p><strong>Objective: </strong>Several clinical studies have explored the feasibility and efficacy of radiosurgical treatment for mesial temporal lobe epilepsy, but the long-term safety of this treatment has not been fully characterized. This study aims to report and describe radiation-induced cavernous malformation as a delayed complication of radiosurgery in epilepsy patients.</p><p><strong>Methods: </strong>The series includes 20 patients with mesial temporal lobe epilepsy who underwent Gamma Knife radiosurgery (GKRS). The majority received a prescribed isodose of 24 Gy as an adjuvant treatment after anterior temporal lobectomy.</p><p><strong>Results: </strong>In this series, we identified radiation-induced cavernous malformation in three patients, resulting in a cumulative incidence of 18.4% (95% confidence interval, 6.3% to 47.0%) at an 8-year follow-up. These late sequelae of vascular malformation occurred between 6.9 and 7.6 years after GKRS, manifesting later than other delayed radiation-induced changes, such as radiation necrosis. Neurological symptoms attributed to intracranial hypertension were present in those three cases involving cavernous malformation. Of these, two cases, which initially exhibited an insufficient response to radiosurgery, ultimately demonstrated seizure remission following the successful microsurgical resection of the cavernous malformation.</p><p><strong>Conclusion: </strong>All things considered, the development of radiation-induced cavernous malformation is not uncommon in this population and should be acknowledged as a potential long-term complication. Microsurgical resection of cavernous malformation can be preferentially considered in cases where the initial seizure outcome after GKRS is unsatisfactory.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"458-466"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11220412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71482503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein Requirement Changes According to the Treatment Application in Neurocritical Patients. 神经危重症患者蛋白质需要量随治疗应用的变化。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-21 DOI: 10.3340/jkns.2023.0176
Jungook Kim, Youngbo Shim, Yoon-Hee Choo, Hye Seon Kim, Young Ran Kim, Eun Jin Ha

Objective: Exploring protein requirements for critically ill patients has become prominent. On the other hand, considering the significant impact of coma therapy and targeted temperature management (TTM) on the brain as well as systemic metabolisms, protein requirements may plausibly be changed by treatment application. However, there is currently no research on protein requirements following the application of these treatments. Therefore, the aim of this study is to elucidate changes in patients' protein requirements during the application of TTM and coma therapy.

Methods: This study is a retrospective analysis of prospectively collected data from March 2019 to May 2022. Among the patients admitted to the intensive care unit, those receiving coma therapy and TTM were included. The patient's treatment period was divided into two phases (phase 1, application and maintenance of coma therapy and TTM; phase 2, tapering and cessation of treatment). In assessing protein requirements, the urine urea nitrogen (UUN) method was employed to estimate the nitrogen balance, offering insight into protein utilization within the body. The patient's protein requirement for each phase was defined as the amount of protein required to achieve a nitrogen balance within ±5, based on the 24-hour collection of UUN. Changes in protein requirements between phases were analyzed.

Results: Out of 195 patients, 107 patients with a total of 214 UUN values were included. The mean protein requirement for the entire treatment period was 1.84±0.62 g/kg/day, which is higher than the generally recommended protein supply of 1.2 g/kg/day. As the treatment was tapered, there was a statistically significant increase in the protein requirement from 1.49±0.42 to 2.18±0.60 in phase 2 (p<0.001).

Conclusion: Our study revealed a total average protein requirement of 1.84±0.62 g during the treatment period, which falls within the upper range of the preexisting guidelines. Nevertheless, a notable deviation emerged when analyzing the treatment application period separately. Hence, it is recommended to incorporate considerations for the type and timing of treatment, extending beyond the current guideline, which solely accounts for the severity by disease.

目的:探讨危重病人的蛋白质需要量已成为当务之急。另一方面,考虑到昏迷治疗和靶向温度管理(TTM)对大脑和全身代谢的重大影响,蛋白质需求可能会因治疗应用而改变。然而,目前还没有研究在应用这些处理后的蛋白质需求。因此,本研究的目的是阐明在应用TTM和昏迷治疗过程中患者蛋白质需求的变化。方法:对2019年3月至2022年5月前瞻性采集的数据进行回顾性分析。重症监护病房的患者包括接受昏迷治疗和TTM治疗的患者。患者的治疗期分为两个阶段(第一阶段:应用和维持昏迷治疗和TTM;第2阶段:逐渐减少和停止治疗)。在评估蛋白质需求时,采用尿尿素氮(UUN)方法来估计氮平衡,从而深入了解体内蛋白质的利用情况。根据24小时收集的UUN,将患者每个阶段的蛋白质需求量定义为在±5内达到氮平衡所需的蛋白质量。分析各期蛋白质需要量的变化。结果:195例患者中,纳入107例患者,共214个UUN值。整个处理期平均蛋白质需要量为1.84±0.62 g/kg/d,高于一般推荐的1.2 g/kg/d。随着治疗的逐渐减少,第二阶段蛋白质需求量从1.49±0.42增加到2.18±0.60,具有统计学意义(p < 0.001)。结论:我们的研究显示,在治疗期间,总平均蛋白质需要量为1.84±0.62g,处于现有指南的上限范围内。然而,在单独分析处理应用期时,出现了明显的偏差。因此,建议将治疗的类型和时机纳入考虑,超越目前仅考虑疾病严重程度的指南。
{"title":"Protein Requirement Changes According to the Treatment Application in Neurocritical Patients.","authors":"Jungook Kim, Youngbo Shim, Yoon-Hee Choo, Hye Seon Kim, Young Ran Kim, Eun Jin Ha","doi":"10.3340/jkns.2023.0176","DOIUrl":"10.3340/jkns.2023.0176","url":null,"abstract":"<p><strong>Objective: </strong>Exploring protein requirements for critically ill patients has become prominent. On the other hand, considering the significant impact of coma therapy and targeted temperature management (TTM) on the brain as well as systemic metabolisms, protein requirements may plausibly be changed by treatment application. However, there is currently no research on protein requirements following the application of these treatments. Therefore, the aim of this study is to elucidate changes in patients' protein requirements during the application of TTM and coma therapy.</p><p><strong>Methods: </strong>This study is a retrospective analysis of prospectively collected data from March 2019 to May 2022. Among the patients admitted to the intensive care unit, those receiving coma therapy and TTM were included. The patient's treatment period was divided into two phases (phase 1, application and maintenance of coma therapy and TTM; phase 2, tapering and cessation of treatment). In assessing protein requirements, the urine urea nitrogen (UUN) method was employed to estimate the nitrogen balance, offering insight into protein utilization within the body. The patient's protein requirement for each phase was defined as the amount of protein required to achieve a nitrogen balance within ±5, based on the 24-hour collection of UUN. Changes in protein requirements between phases were analyzed.</p><p><strong>Results: </strong>Out of 195 patients, 107 patients with a total of 214 UUN values were included. The mean protein requirement for the entire treatment period was 1.84±0.62 g/kg/day, which is higher than the generally recommended protein supply of 1.2 g/kg/day. As the treatment was tapered, there was a statistically significant increase in the protein requirement from 1.49±0.42 to 2.18±0.60 in phase 2 (p<0.001).</p><p><strong>Conclusion: </strong>Our study revealed a total average protein requirement of 1.84±0.62 g during the treatment period, which falls within the upper range of the preexisting guidelines. Nevertheless, a notable deviation emerged when analyzing the treatment application period separately. Hence, it is recommended to incorporate considerations for the type and timing of treatment, extending beyond the current guideline, which solely accounts for the severity by disease.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"451-457"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11220411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138176385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Detection of hyperemia with Magnetic Resonance Fluid Attenuation Inversion Recovery Imaging after Superficial Temporal Artery to Middle Cerebral Artery Anastomosis. 颞浅动脉-大脑中动脉吻合术后磁共振液体衰减反转恢复成像早期检测充血。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-21 DOI: 10.3340/jkns.2023.0183
Jin Eun, Ik Seong Park

Objective: Cerebral hyperperfusion syndrome (CHS) manifests as a collection of symptoms brought on by heightened focal cerebral blood flow (CBF), afflicting nearly 30% of patients who have undergone superficial temporal artery (STA)-middle cerebral artery (MCA) anastomosis. The aim of this study was to investigate whether the amalgamation of magnetic resonance imaging (MRI) fluid-attenuated inversion recovery (FLAIR) and apparent diffusion coefficient (ADC) imaging via MRI can discern cerebral hyperemia after STA-MCA anastomosis surgery.

Methods: A retrospective study was performed of patients who underwent STA-MCA anastomosis due to Moyamoya disease or atherosclerotic steno-occlusive disease. A protocol aimed at preventing CHS was instituted, leveraging the use of MRI FLAIR. Patients underwent MRI diffusion with FLAIR imaging 24 hours after STA-MCA anastomosis. A high signal on FLAIR images signified the presence of hyperemia at the bypass site, triggering a protocol of hyperemia care. All patients underwent hemodynamic evaluations, including perfusion MRI, single-photon emission computed tomography (SPECT), and digital subtraction angiography, both before and after the surgery. If a high signal intensity is observed on MRI FLAIR within 24 hours of the surgery, a repeat MRI is performed to confirm the presence of hyperemia. Patients with confirmed hyperemia are managed according to a protocol aimed at preventing further progression.

Results: Out of a total of 162 patients, 24 individuals (comprising 16 women and 8 men) exhibited hyperemia on their MRI FLAIR scans following the procedure. SPECT was conducted on 23 patients, and 11 of them yielded positive results. All 24 patients underwent perfusion MRI, but nine of them showed no significant findings. Among the patients, 10 displayed elevations in both CBF and cerebral blood volume (CBV), three only showed elevation in CBF, and two only showed elevation in CBV. Follow-up MRI FLAIR scans conducted 6 months later on these patients revealed complete normalization of the previously observed high signal intensity, with no evidence of ischemic injury.

Conclusion: The study determined that the use of MRI FLAIR and ADC mapping is a competent means of early detection of hyperemia after STA-MCA anastomosis surgery. The protocol established can be adopted by other neurosurgical institutions to enhance patient outcomes and mitigate the hazard of permanent cerebral injury caused by cerebral hyperemia.

目的:脑高灌注综合征(Cerebral hyperperfusion syndrome, CHS)表现为局灶性脑血流增高引起的一系列症状,近30%行颞浅动脉-大脑中动脉吻合术的患者患有此病。本研究的目的是探讨磁共振成像(MRI)液体衰减反转恢复(FLAIR)和MRI表观扩散系数(ADC)成像合并是否可以识别STA-MCA吻合术后脑充血。方法:对因烟雾病或动脉粥样硬化性狭窄闭塞病行STA-MCA吻合的患者进行回顾性研究。制定了一项旨在预防CHS的方案,利用MRI FLAIR的使用。STA-MCA吻合后24小时行MRI弥散FLAIR显像。FLAIR图像上的高信号表明旁路部位充血,触发充血护理方案。所有患者在手术前和术后均接受血流动力学评估,包括灌注MRI、单光子发射计算机断层扫描(SPECT)和数字减影血管造影。如果在手术后24小时内MRI FLAIR上观察到高信号强度,则复查MRI以确认充血的存在。确认充血的患者根据旨在防止进一步进展的方案进行管理。结果:在总共162例患者中,24人(包括16名女性和8名男性)在手术后的MRI FLAIR扫描中表现出充血。23例患者行SPECT检查,其中11例阳性。24例患者均行灌注MRI检查,其中9例无明显表现。10例患者脑血流量(CBF)和脑血容量(CBV)同时升高,3例仅CBF升高,2例仅CBV升高。6个月后对这些患者进行的随访MRI FLAIR扫描显示,先前观察到的高信号强度完全正常化,没有缺血性损伤的证据。结论:本研究确定MRI FLAIR和ADC定位是STA-MCA吻合术后早期充血的有效手段。所建立的方案可被其他神经外科机构采用,以提高患者的预后,减轻脑充血引起永久性脑损伤的危险。
{"title":"Early Detection of hyperemia with Magnetic Resonance Fluid Attenuation Inversion Recovery Imaging after Superficial Temporal Artery to Middle Cerebral Artery Anastomosis.","authors":"Jin Eun, Ik Seong Park","doi":"10.3340/jkns.2023.0183","DOIUrl":"10.3340/jkns.2023.0183","url":null,"abstract":"<p><strong>Objective: </strong>Cerebral hyperperfusion syndrome (CHS) manifests as a collection of symptoms brought on by heightened focal cerebral blood flow (CBF), afflicting nearly 30% of patients who have undergone superficial temporal artery (STA)-middle cerebral artery (MCA) anastomosis. The aim of this study was to investigate whether the amalgamation of magnetic resonance imaging (MRI) fluid-attenuated inversion recovery (FLAIR) and apparent diffusion coefficient (ADC) imaging via MRI can discern cerebral hyperemia after STA-MCA anastomosis surgery.</p><p><strong>Methods: </strong>A retrospective study was performed of patients who underwent STA-MCA anastomosis due to Moyamoya disease or atherosclerotic steno-occlusive disease. A protocol aimed at preventing CHS was instituted, leveraging the use of MRI FLAIR. Patients underwent MRI diffusion with FLAIR imaging 24 hours after STA-MCA anastomosis. A high signal on FLAIR images signified the presence of hyperemia at the bypass site, triggering a protocol of hyperemia care. All patients underwent hemodynamic evaluations, including perfusion MRI, single-photon emission computed tomography (SPECT), and digital subtraction angiography, both before and after the surgery. If a high signal intensity is observed on MRI FLAIR within 24 hours of the surgery, a repeat MRI is performed to confirm the presence of hyperemia. Patients with confirmed hyperemia are managed according to a protocol aimed at preventing further progression.</p><p><strong>Results: </strong>Out of a total of 162 patients, 24 individuals (comprising 16 women and 8 men) exhibited hyperemia on their MRI FLAIR scans following the procedure. SPECT was conducted on 23 patients, and 11 of them yielded positive results. All 24 patients underwent perfusion MRI, but nine of them showed no significant findings. Among the patients, 10 displayed elevations in both CBF and cerebral blood volume (CBV), three only showed elevation in CBF, and two only showed elevation in CBV. Follow-up MRI FLAIR scans conducted 6 months later on these patients revealed complete normalization of the previously observed high signal intensity, with no evidence of ischemic injury.</p><p><strong>Conclusion: </strong>The study determined that the use of MRI FLAIR and ADC mapping is a competent means of early detection of hyperemia after STA-MCA anastomosis surgery. The protocol established can be adopted by other neurosurgical institutions to enhance patient outcomes and mitigate the hazard of permanent cerebral injury caused by cerebral hyperemia.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"442-450"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11220419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138176384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telemedicine Protocols for the Management of Patients with Acute Spontaneous Intracerebral Hemorrhage in Rural and Medically Underserved Areas in Gangwon State : Recommendations for Doctors with Less Expertise at Local Emergency Rooms. 江原州农村和医疗服务不足地区急性自发性脑出血患者管理的远程医疗协议:对当地急诊室专业知识较少的医生的建议。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-07-01 Epub Date: 2023-10-30 DOI: 10.3340/jkns.2023.0199
Hyo Sub Jun, Kuhyun Yang, Jongyeon Kim, Jin Pyeong Jeon, Sun Jeong Kim, Jun Hyong Ahn, Seung Jin Lee, Hyuk Jai Choi, In Bok Chang, Jeong Jin Park, Jong-Kook Rhim, Sung-Chul Jin, Sung Min Cho, Sung-Pil Joo, Seung Hun Sheen, Sang Hyung Lee

Previously, we reported the concept of a cloud-based telemedicine platform for patients with intracerebral hemorrhage (ICH) at local emergency rooms in rural and medically underserved areas in Gangwon state by combining artificial intelligence and remote consultation with a neurosurgeon. Developing a telemedicine ICH treatment protocol exclusively for doctors with less ICH expertise working in emergency rooms should be part of establishing this system. Difficulties arise in providing appropriate early treatment for ICH in rural and underserved areas before the patient is transferred to a nearby hub hospital with stroke specialists. This has been an unmet medical need for decade. The available reporting ICH guidelines are realistically possible in university hospitals with a well-equipped infrastructure. However, it is very difficult for doctors inexperienced with ICH treatment to appropriately select and deliver ICH treatment based on the guidelines. To address these issues, we developed an ICH telemedicine protocol. Neurosurgeons from four university hospitals in Gangwon state first wrote the guidelines, and professors with extensive ICH expertise across the country revised them. Guidelines and recommendations for ICH management were described as simply as possible to allow more doctors to use them easily. We hope that our effort in developing the telemedicine protocols will ultimately improve the quality of ICH treatment in local emergency rooms in rural and underserved areas in Gangwon state.

此前,我们报道了一个基于云的远程医疗平台的概念,该平台通过将人工智能和神经外科医生的远程会诊相结合,为江原州农村和医疗服务不足地区的当地急诊室的脑出血患者提供远程医疗平台。专门为在急诊室工作的脑出血专业知识较少的医生制定远程医疗脑出血治疗方案应该是建立该系统的一部分。在农村和服务不足的地区,在将患者转移到附近的中风专家中心医院之前,很难为脑出血提供适当的早期治疗。十年来,这一直是一个未得到满足的医疗需求。现有的ICH报告指南在拥有完善基础设施的大学医院中是可行的。然而,对于缺乏脑出血治疗经验的医生来说,很难根据指南适当选择和提供脑出血治疗。为了解决这些问题,我们制定了ICH远程医疗协议。江原道四所大学医院的神经外科医生首先编写了该指南,全国各地拥有丰富非物质文化遗产专业知识的教授对其进行了修订。ICH管理的指南和建议被描述得尽可能简单,以便让更多的医生能够轻松使用。我们希望,我们制定远程医疗协议的努力将最终提高江原州农村和服务不足地区当地急诊室的脑出血治疗质量。
{"title":"Telemedicine Protocols for the Management of Patients with Acute Spontaneous Intracerebral Hemorrhage in Rural and Medically Underserved Areas in Gangwon State : Recommendations for Doctors with Less Expertise at Local Emergency Rooms.","authors":"Hyo Sub Jun, Kuhyun Yang, Jongyeon Kim, Jin Pyeong Jeon, Sun Jeong Kim, Jun Hyong Ahn, Seung Jin Lee, Hyuk Jai Choi, In Bok Chang, Jeong Jin Park, Jong-Kook Rhim, Sung-Chul Jin, Sung Min Cho, Sung-Pil Joo, Seung Hun Sheen, Sang Hyung Lee","doi":"10.3340/jkns.2023.0199","DOIUrl":"10.3340/jkns.2023.0199","url":null,"abstract":"<p><p>Previously, we reported the concept of a cloud-based telemedicine platform for patients with intracerebral hemorrhage (ICH) at local emergency rooms in rural and medically underserved areas in Gangwon state by combining artificial intelligence and remote consultation with a neurosurgeon. Developing a telemedicine ICH treatment protocol exclusively for doctors with less ICH expertise working in emergency rooms should be part of establishing this system. Difficulties arise in providing appropriate early treatment for ICH in rural and underserved areas before the patient is transferred to a nearby hub hospital with stroke specialists. This has been an unmet medical need for decade. The available reporting ICH guidelines are realistically possible in university hospitals with a well-equipped infrastructure. However, it is very difficult for doctors inexperienced with ICH treatment to appropriately select and deliver ICH treatment based on the guidelines. To address these issues, we developed an ICH telemedicine protocol. Neurosurgeons from four university hospitals in Gangwon state first wrote the guidelines, and professors with extensive ICH expertise across the country revised them. Guidelines and recommendations for ICH management were described as simply as possible to allow more doctors to use them easily. We hope that our effort in developing the telemedicine protocols will ultimately improve the quality of ICH treatment in local emergency rooms in rural and underserved areas in Gangwon state.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"385-396"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11220410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71412571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Korean Neurosurgical Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1